P. Halcrow

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index645citations6works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(4), HER2/EGFR in Cancer Research(4), Estrogen and related hormone effects(2), Cancer survivorship and care(1), Lymphoma Diagnosis and Treatment(1)

Publications6 total

Using a collaborative approach to measure patient satisfaction of supportive care throughout the breast cancer journey
European Journal of Cancer·2001
Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup
British Journal of Cancer·1991· 166 citedOpen Access
Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure
The Journal of Steroid Biochemistry and Molecular Biology·1990· 146 cited
A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-Bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738)
European Journal of Cancer and Clinical Oncology·1989· 1 cited
EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER
The Lancet·1989· 218 cited
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer
British Journal of Cancer·1988· 114 citedOpen Access

Frequent Co-authors

Adrian L. Harris(5), S Nicholson(4), J R C Sainsbury(3), Brian Angus(3), J R Farndon(2), P. L. Chambers(2), J Richard(1), Christopher Sainsbury(1), Peter J. Kelly(1), C Wright(1), James A. Henry(1), Christopher Wright(1), Peter J. Kelly(1), John R. FarnVon(1), JR Farndon(1), Thomas W. J. Lennard(1), Jonathan M. Hales(1), Anne M. Dickinson(1), R. A. Wolstencroft(1), B.K. Shenton(1)